Long-Surviving Patients with Recurrent GIST after Receiving Cytoreductive Surgery with Imatinib Therapy

In the treatment of recurrent or metastatic gastrointestinal stromal tumors (GIST), good prognoses may not be expected by surgery alone. Recently, imatinib has been applied for the treatment of GISTs, resulting in improved patient survival. However, long-term success is limited due to the developmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Won Hyuk, Kim, Sungsoo, Hyung, Woo Jin, Yu, Jeong Sik, Park, Chan Il, Choi, Seung Ho, Noh, Sung Hoon
Formato: Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2009
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2703769/
https://www.ncbi.nlm.nih.gov/pubmed/19568608
http://dx.doi.org/10.3349/ymj.2009.50.3.437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2703769/
https://www.ncbi.nlm.nih.gov/pubmed/19568608
http://dx.doi.org/10.3349/ymj.2009.50.3.437

Ejemplares similares